Inflammatory Bowel Diseases

Aims & Scope

Inflammatory Bowel Diseases® (IBD) supports the mission of the Crohn's & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields.

The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.

The Journal publishes peer-reviewed manuscripts and review articles in basic and clinical sciences, updates on clinical trials, reviews of the current literature, editorials, and other features.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.3
2024	4.50

Journal Rank

Year	Value
2024	1766

Journal Citation Indicator

Year	Value
2024	3486

SJR (SCImago Journal Rank)

Year	Value
2024	1.780

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	183

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Pediatric modification of the Montreal classification for inflammatory bowel disease

  Citation: 1264

  Authors: Arie, Anne, James, David C, Dan, Richard K, John, Frank M, Thomas, Mary, Marla, Jeffrey S

• Long-Term Evolution of Disease Behavior of Crohn's Disease

  Citation: 1123

  Authors: Jacques, Stéphane, Antoine, Laurent, Franck, Rolland, Jean-Pierre

• Low counts of Faecalibacterium prausnitzii in colitis microbiota

  Citation: 1023

  Authors: H., P., J. P., O., I., L., J., G., P., J.

• Current Understanding of Dysbiosis in Disease in Human and Animal Models

  Citation: 861

  Authors: Arianna K., Daren, Atsushi, Emiko

• Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

  Citation: 766

  Authors: James D., Shaokun, Lisa, Gary R., Faten N., Jonas H.

• Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

  Citation: 766

  Authors: Eric I., Kyle J., Peter, Meta, Johan, Anne M.

• A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

  Citation: 697

  Authors: Christoph, Jurgen, Jorn, Geert, Stephen B., Jan E., Derek P., Daniel, David B., William J., Lloyd R.

• Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

  Citation: 675

  Authors: Geert, Marc, Severine, Filip, Maja, Liesbeth, Patricia, Doreen, Isolde, Gert, Gust, Paul

• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  Citation: 666

  Authors: Stephen B

• Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis

  Citation: 631

  Authors: Philip, Nicholas C., Thuan, Liberty, Tian-E, Laurie S., Michael, Xuhang

---